3 completed, 1 unknown. 2 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Cipher Pharmaceuticals Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies Spinosad Topical - Scabies | Phase 4 | Unknown | Cipher Pharmaceuticals Inc. | 50 | 2022-03-04 | 2025-02-14 |
| Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants Tramadol HCl, Moxifloxacin 400 mg, Tramadol HCl Placebo - Healthy | Phase 1 | Completed | Janssen Scientific Affairs, LLC | 68 | 2014-12-04 | 2018-08-29 |
| A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers Tramadol HCl, 50 mg, Placebo - Healthy | Phase 1 | Completed | Janssen Scientific Affairs, LLC | 30 | 2013-08-01 | 2014-12-16 |
| Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne CIP-Isotretinoin, Isotretinoin - Severe Nodular Acne | Phase 3 | Completed | Cipher Pharmaceuticals Inc. | 925 | 2009-09-01 | 2014-07-04 |
Long QT Syndrome (1) · Pain (1) · Scabies (1)
Tramadol (2) · Benzyl Alcohol (1) · Isotretinoin (1) · Moxifloxacin (1) · spinosad (1)
United States (4) · Canada (1)
Guy Webster, MD (1) · James J. Leyden, MD (1) · Jason A. Gross, PharmD (1) · Julie Aker, MT(ASCP) (1) · Sharda Angl (1) · William Miller, MD (1)